Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport

RPF Dullaart; Aad Tol

doi:10.1046/j.1464-5491.2001.00507.x

Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport

RPF Dullaart, Aad Tol

Biochemistry

Research output: Contribution to journal › Article › Academic › peer-review

6 Citations (Scopus)

1 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	509-513
Number of pages	5
Journal	Diabetic Medicine
Volume	18
DOIs	https://doi.org/10.1046/j.1464-5491.2001.00507.x
Publication status	Published - 2001

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1046/j.1464-5491.2001.00507.x

Dullaart_et_al-2001-Diabetic_Medicine.pdfFinal published version, 75.2 KB

http://hdl.handle.net/1765/64915

Cite this

@article{93a9d101d7304a98b6342a05c4eb4213,

title = "Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport",

author = "RPF Dullaart and Aad Tol",

year = "2001",

doi = "10.1046/j.1464-5491.2001.00507.x",

language = "Undefined/Unknown",

volume = "18",

pages = "509--513",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell Publishing Ltd",

}

TY - JOUR

T1 - Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport

AU - Dullaart, RPF

AU - Tol, Aad

PY - 2001

Y1 - 2001

U2 - 10.1046/j.1464-5491.2001.00507.x

DO - 10.1046/j.1464-5491.2001.00507.x

M3 - Article

VL - 18

SP - 509

EP - 513

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

ER -